March 21th and 22th, 2023in Lyon, FranceFor this 2023 edition, Biofortis will be present during the Pharmabiotic...
![[EVENT] – Biofortis will be present at PHARMABIOTICS 2023](https://www.biofortis.fr/wp-content/uploads/2023/02/Post-SM_Pharmabiotics-2023-1080x675.jpg)
News
![[NEWS] Welcome aboard Morgan and Fanny!](https://www.biofortis.fr/wp-content/uploads/2022/11/Welcome-MC-et-FD-1-1080x675.png)
[NEWS] Welcome aboard Morgan and Fanny!
We are pleased to welcome Morgan Cabigliera, as Head of the Sales & Marketing Business Unit and Fanny Doistau, as...
![[Le French Gut] – Biofortis is part of the national project Le French Gut, to accelerate the science of the microbiota](https://www.biofortis.fr/wp-content/uploads/2022/09/Visuel-SM-1080x675.png)
[Le French Gut] – Biofortis is part of the national project Le French Gut, to accelerate the science of the microbiota
Biofortis as a unique full service CRO providing Nutrition Clinical Trials, Microbiome Investigation and Data Science...
[EVENT] Atelier “Le microbiome, un compagnon des développements thérapeutiques : fondamentaux, savoir-faire et pratique”
31 mars 2021 de 9h30 à 12h : Atelier produits de santé et microbiomeA l’occasion du Printemps de la Recherche Clinique de l’AFCROs, Biofortis vous propose un atelier autour du thème “Le microbiome, un compagnon des développements thérapeutiques : fondamentaux,...
[EVENT] – Microbiome Drug Development Europe 2021
5th Microbiome Movement Drug Development Europe 2021 28th-29th of January Come and e-meet us at the 5th Microbiome Movement – Drug Development Europe 2021 Congress to learn more about microbiome drug development We will be present the 2 days of event - 28th to 29th of...
![[NEWS] Biofortis opens additional clinical investigation unit facility](https://www.biofortis.fr/wp-content/uploads/2020/12/Nouvel-UIC--e1609845097905-366x250.gif)
[NEWS] Biofortis opens additional clinical investigation unit facility
[NEWS] Biofortis opens additional clinical investigation unit facility Biofortis is pleased to announce the opening of a new clinical investigation unit in Paris approved by Local Health Agency. Biofortis is a CRO whose main activity is the performance of clinical...
[WEBINAR] Bioinformatic and Statistics tools: From raw data to conclusions – Dec 15th – 5pm CET
WEBINAR PART II // Bioinformatic and Statistics tools: From raw data to conclusions Dec 15th - 5pm CET This webinar will be presented by: – SPEAKERS: Diego Tomassi: Data Scientist, PhD Sébastien Leuillet: Chief Technology Officer – MODERATOR: Stéphane Deniau:...
Global Engage: Microbiome & Probiotics R&D & Business Collaboration Forum: Europe
Global Engage Microbiome & Probiotics R&D & Business Collaboration Forum: Europe Nov 30th- Dec 1st We will attend Virtually Global Engage, Microbiome & Probiotics R&D & Business Collaboration Forum: Europe as Gold Sponsor from Nov 30 and Dec...
COVID-19 – Biofortis’ Continuity Plan
UPDATE - November 4th of 2020 The French President has announced a 30-day lockdown requiring the majority of residents to remain at home. Please know that our two Biofortis clinical centers (Paris and Nantes) will remain open during this time in accordance with the...